Qianmeng Lin
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Fibroblast Growth Factor Research 7
- Epigenetics and DNA Methylation 3
-
- Pharmacogenetics and Drug Metabolism 9
- Co-authors
- Guoxin Hu (9 shared papers)Ren-ai Xu (8 shared papers)Xiangjun Qiu (3 shared papers)Yongheng Chen (9 shared papers)Jingjing Chen (2 shared papers)Yuanyuan Shao (2 shared papers)Guanyang Lin (1 shared paper)Lingzhi Qu (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Communications Chemistry (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)European Journal of Medicinal Chemistry (2 papers)Chemical Research in Toxicology (2 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Qianmeng Lin
25 papers receiving 308 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 63
- Hematology 26
- Genetics 22
- Oncology 55
- Hepatology 15
Countries citing papers authored by Qianmeng Lin
This map shows the geographic impact of Qianmeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianmeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianmeng Lin more than expected).
Fields of papers citing papers by Qianmeng Lin
This network shows the impact of papers produced by Qianmeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianmeng Lin. The network helps show where Qianmeng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Qianmeng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2022 | 34 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 27 | |
| 5 | 2019 | 19 | |
| 6 | 2022 | 15 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 12 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2019 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2018 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2019 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2024 | 4 |
About Qianmeng Lin
Qianmeng Lin is a scholar working on Molecular Biology, Pharmacology, Oncology, Rheumatology and Hematology, having authored 27 papers that have together received 308 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Fibroblast Growth Factor Research (7 papers), Eosinophilic Disorders and Syndromes (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Diabetes Treatment and Management (3 papers), Epigenetics and DNA Methylation (3 papers), Liver physiology and pathology (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pharmacology (63 citations), Hematology (26 citations), Genetics (22 citations), Oncology (55 citations) and Hepatology (15 citations). Qianmeng Lin has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Guoxin Hu, Ren-ai Xu, Xiangjun Qiu, Yongheng Chen, Jingjing Chen, Yuanyuan Shao, Guanyang Lin, Lingzhi Qu, Hudie Wei and Ming Guo. Their work appears in journals such as Journal of Medicinal Chemistry, Communications Chemistry, Journal of Pharmaceutical and Biomedical Analysis, European Journal of Medicinal Chemistry and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.